期刊文献+

清肝解毒降酶汤治疗慢性乙型病毒性肝炎YMDD变异患者52例临床观察 被引量:5

Clinical Research on52Cases of Chronic Virus B Hepatitis with YMDD Mutation Treated by QingGan JieDu JiangMei Decoction
下载PDF
导出
摘要 目的:观察清肝解毒降酶汤对慢性乙型病毒性肝炎YMDD变异患者的治疗作用。方法:将99例慢性乙型病毒性肝炎YMDD变异患者分为治疗组52例,对照组47例。治疗组予清肝解毒降酶汤,每日1剂煎服;对照组予益肝灵片剂,每次1片,每日3次口服。4周后观察两组血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、—谷氨酰转移酶(GGT)的变化情况。结果:治疗组总有效率88.46%,对照组总有效率68.09%,治疗组疗效优于对照组(P<0.05);肝功能中ALT、AST、GGT值治疗组治疗后均低于对照组(P<0.05或P<0.01)。结论:清肝解毒降酶汤能有效降低慢性乙型病毒性肝炎YMDD变异患者的肝功能指标水平,其疗效明显优于对照组。 Objective: To study the curative effects of QingGan JieDu JiangMei Decoction on chronic virus B hepatitis with YMDD mutation. Methods: 99 eases of chronic virus B hepatitis with YMDD mutation were divided into two groups. The treatment group with 52 eases was treated with QingGan JieDu JiangMei Decoction 1 dose/day, while the control group with 47 cases was given YiC, anLing Tablet 1 pill/time, three times per day. Four weeks later, the observation was made to see the changes of ALT, AST, and GGT in both two groups. Results: The curative effects in the treatment group with the total effective rate as 88.46% were better than in the control group with the rate as 68.09% (P 〈 0.05) . Meanwhile, ALT, AST, and GGT were lowered more obviously in the treatment group (P 〈 0.05 or P 〈 0.01). Conclusions: QingGan JieDu JiangMei Decoction can effectively lower the levels of ALT, AST, and GGT in patients of chronic virus B hepatitis with YMDD mutation. And its curative effects are better than the control group.
出处 《广西中医药》 2005年第5期6-8,共3页 Guangxi Journal of Traditional Chinese Medicine
关键词 慢性乙型病毒性肝炎 YMDD变异 清肝解毒降酶汤 中医药疗法 Chronic virus B hepatitis YMDD mutation QingGan JieDu JiangMei Decoction TCM treatment
  • 相关文献

参考文献4

二级参考文献7

  • 1戴志澄 祁国明 等.乙肝病毒性肝炎的流行特征,中国病毒性肝炎血清流行病学调查1992-1995[M].北京:科学技术文献出版社,1997.39-59.
  • 2Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview.Semin Virol, 1993,4:273-283.
  • 3Lai CL, Chien RN, Leung NWY, et al. A one-year trial of lamivudine for chronic hepatitis B. NEJM, 1998,339:61-68.
  • 4Kobayashi Satsuki, Ide Tatsuya, Sata Miehio, et al. Detection of YMDD motif mutations in some lamivudine~untreated asymptomatic hepatitis B virus carriers. J Hepatol, 2001,34 : 584-586.
  • 5Kirishima Toshihiko, Okanoue Takeshi, Daimon Yukiko, et al.Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. J Hepatol, 2002, 37: 259-265.
  • 6拉米夫定临床应用专家指导小组.2000年拉米夫定临床应用指导意见[J].中华肝脏病杂志,2000,8(4):249-250. 被引量:114
  • 7拉米夫定临床应用专家指导小组.2001年拉米夫定临床应用专家共识[J].中华肝脏病杂志,2002,10(2):157-158. 被引量:71

共引文献14068

同被引文献77

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部